Actively Recruiting
Phase 1 Study to Evaluate Safety and Effects of Single and Multiple Doses of SAL0140, Including Food Impact, in Healthy Chinese Adults
Led by Shenzhen Salubris Pharmaceuticals Co., Ltd. · Updated on 2025-07-04
82
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying SAL0140 to assess its safety, tolerability, and how the body processes and responds to the drug in healthy Chinese adults aged 18 to 65 years. This Phase 1 trial includes adults of both genders and aims to understand the effects of SAL0140 through different dosing strategies. The trial also examines how food intake affects the drugs behavior in the body, contributing to a comprehensive evaluation. The study consists of three parts. Part A involves a single ascending dose design where participants receive increasing oral doses of SAL0140 or placebo to assess safety and drug effects. Part B uses a two-period crossover design to evaluate the impact of food on the drugs pharmacokinetics with single doses. Part C is a multiple ascending dose study, with participants receiving repeated doses of SAL0140 or placebo. Each part enrolls separate groups, and participants take either the study drug or placebo according to random assignment. Participants will undergo health assessments including physical exams, vital signs, lab tests, ECGs, and chest X-rays to monitor safety. Researchers will track adverse events and heart activity from dosing through follow-up days. The study carefully monitors participants up to 28 days after dosing to observe any side effects or changes in heart function. Each participant only joins one dosing group in one part of the study, with the total duration depending on the assigned group.
CONDITIONS
Brief Title
SAL0140 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population
Research Team
C
Chongyuan Xu, Ph.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here